ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

VELA Vela Technologies Plc

0.0125
0.0005 (4.17%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vela Technologies Plc LSE:VELA London Ordinary Share GB00BYZ9XC29 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0005 4.17% 0.0125 0.012 0.013 0.0125 0.012 0.01 17,270,512 14:42:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 0 -378k 0.0000 N/A 1.63M
Vela Technologies Plc is listed in the Investment Advice sector of the London Stock Exchange with ticker VELA. The last closing price for Vela Technologies was 0.01p. Over the last year, Vela Technologies shares have traded in a share price range of 0.0115p to 0.0335p.

Vela Technologies currently has 16,252,335,184 shares in issue. The market capitalisation of Vela Technologies is £1.63 million.

Vela Technologies Share Discussion Threads

Showing 226 to 249 of 7975 messages
Chat Pages: Latest  19  18  17  16  15  14  13  12  11  10  9  8  Older
DateSubjectAuthorDiscuss
09/11/2015
14:07
And Mr 1,640 decides 4hours is too long here, you couldn't make it up.

DC

daicaprice
09/11/2015
14:04
10m v 1m and we're showing red, yea right.

DC

daicaprice
09/11/2015
10:28
Volume picking up nicely now, looks like there's a delayed sell to show but all very encouraging.

DC

daicaprice
09/11/2015
10:02
Took another 500k.

DC

daicaprice
09/11/2015
09:22
A few people arriving this morning looking for a trade, welcome all.

DC

daicaprice
06/11/2015
04:50
BlockchainTech transaction completed in CanadaUpdate should be coming outhttp://m.marketwired.com/press-release/northern-aspect-announces-closing-qualifying-transaction-with-blockchain-tech-ltd-changes-2070484.htm
alexios1201
05/11/2015
15:04
Watch this little holding in 3legs growing nicely
alexios1201
04/11/2015
16:29
Another 1m+ taken bodes well for the rest of the week even without news.

DC

daicaprice
04/11/2015
16:12
Nice bit of buying and a couple of ticks up, I was concerned that the 3 legs suspension might spook a few early doors but all looking great.

DC

daicaprice
04/11/2015
08:22
Vela owns just under 4% of 3 Legs
edcrane
04/11/2015
08:01
Sounds positive with a plan B to me.

DC

daicaprice
04/11/2015
07:58
News this morning. Fingers crossed the RTO is near


04 November 2015

3Legs Resources plc

("3Legs" or the "Company")

Proposed Acquisition and Suspension of Trading

3Legs announces that, in accordance with Rule 15 of the AIM Rules for Companies ("AIM Rules"), the Company's shares have been suspended from trading on AIM from 7.30 a.m. today as a result of the Company not having completed an acquisition which constitutes a reverse takeover under the AIM Rules, or otherwise implemented its investing policy within 12 months of becoming an investing company. The Company is actively working to implement its investing policy and the Board is pleased to provide the following update.

The Company has recently signed non-binding heads of terms in connection with the proposed acquisition of SalvaRx Limited ("SalvaRx"), a company in which 3Legs owns an 11.1 per cent. shareholding. On 30 September, the Company reported that it had subscribed GBP215,000 for new shares in SalvaRx in conjunction with a subscription for the same amount by Jim Mellon and Greg Bailey, both directors and substantial shareholders of 3Legs.

SalvaRx owns 60.5% of iOx Therapeutics Limited ("iOx"), a new company which is developing a series of compounds for cancer immunotherapy. As previously announced, iOx's technology is based on a discovery by Professor Vincenzo Cerundolo MD, PhD, the Director of the Human Immunology Unit at the Weatherall Institute of Molecular Medicine at Oxford University and supported by the Ludwig Institute for Cancer Research. Its compounds stimulate invariant natural killer T cells, and preclinical testing in several cancer models suggest the compounds can inhibit the growth of tumours.

The transaction, should it proceed, will be structured by way of an acquisition of all the shares in SalvaRx not already owned by Company with the consideration being satisfied by the issue of new shares in the Company. Due to its size in relation to the Company, the proposed acquisition of SalvaRx would constitute a "reverse takeover" under the AIM Rules. Therefore the Company's shares will remain suspended until such time as either an admission document setting out details of the proposed acquisition is published or, in the event that the transaction does not proceed, the Company has taken other steps to implement its Investing Policy.

In the event that the Company is unable to implement its investing policy within the next six months (i.e. by 4 May 2016), admission of the Company's shares will be cancelled in accordance with Rule 41 of the AIM Rules.

edcrane
02/11/2015
23:18
That was quick, thanks whoever sorted it.

DC

daicaprice
02/11/2015
21:56
alexios will you please do it, it's not doing us any favours if we are trying to attract new investors to the VELA story.
Many thanks in anticipation.

DC

daicaprice
02/11/2015
21:18
Post 233 needs to remove/ edit that long link I think
techair
01/11/2015
21:49
Why has this become tiny on my screen?

Dc

daicaprice
30/10/2015
15:52
Quick Linksimage: Join the Community | Sign In×Get our best content in your email.Best of StockhouseStockhouse @ The BellStockhouse AlertStockhouse News BlastStockhouse Short ReportPrivate Equity Enter your email addressSubmitCloseBy providing my email address, I consent to receiving messages from Stockhouse. image: image: Stockhouse.com LogoHomeCommunityMarketsNewsOpinionPortfolioVideoETFsSearch News, Quotes & Companies×CloseWelcome back to Stockhouse Member Sign In Email or Username Password Sign inRemember me I don't know my passwordorSign in with one of the following accounts.×CloseBecome a member today, It's free!We will not release or resell your information to third parties without your permission.Use one of the following accounts.or Enter your email addressSubmitBy providing my email, I consent to receiving investment related electronic messages from Stockhouse.Disclaimer and Privacy PolicyNews > Press ReleasesNorthern Aspect Provides Update on Development of Blockchain Tech Ltd.'s BusinessV.NTH.H | September 30, 2015CALGARY, ALBERTA--(Marketwired - Sept. 30, 2015) -NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICANorthern Aspect Resources Ltd. (NEX:NTH.H) ("NARL" or the "Corporation"), a capital pool company, is pleased to provide a further update on the developments made by Blockchain Tech Ltd. ("BTL") in connection with its remittance business called Interbit. As announced on August 31, 2015, NARL and BTL have entered into a definitive agreement in respect of a proposed acquisition of BTL by NARL (the "Transaction"), and while they work toward completing the Transaction, BTL continues the development of its business.Interbit has now completed its first real money transaction to a mobile phone in the Philippines, marking a major milestone in development of its remittance platform. In October 2015, Interbit plans to test its remittance settlement solution with multiple business partners that serve the global remittance market.BTL is a technology company incorporated under the laws of the Isle of Man whose first technology platform is a remittance business called Interbit with a focus on leveraging blockchain technology to create rapid and cost effective "cash-in cash-out" settlement solutions between the United Kingdom and target countries.Interbit is developing a unified API interface which will seek to create new efficiencies not currently existing in the worldwide remittance market, estimated to be US$583 billion in 2014 (source: The World Bank).See NARL's press releases dated July 21, 2015, July 24, 2015, August 11, 2015, August 31, 2015 and September 17, 2015 for further information about the Transaction, BTL and its business. The Transaction is intended to constitute the "Qualifying Transaction" of NARL, as such term is defined in Policy 2.4 of the TSX Venture Exchange. NARL will issue additional press releases related to the Transaction and related financings and other material information as it becomes available.NARL LoanIn accordance with Section 8.5 of Policy 2.4 of the TSX Venture Exchange (the "Exchange"), and with approval of the Exchange, NARL and BTL have entered into an agreement whereby NARL agreed to advance a loan of CAD$52,405 to BTL (the "Loan"). The Loan is evidenced by a promissory note and bears no interest. BTL has agreed to use the proceeds of the Loan to pay for general and administrative costs and costs and expenses associated with the development of its businessRead more at
alexios1201
30/10/2015
15:51
#VELAhttps://t.co/9kkszfPjHr
alexios1201
30/10/2015
15:51
#VELAInterbit has now completed its first real money transaction to a mobile phone in the Philippines, marking a major milestone.
alexios1201
30/10/2015
14:40
Excellent news.

DC

daicaprice
30/10/2015
14:35
VELA stake in BTL can finally completeWin win
alexios1201
30/10/2015
14:34
Blockchain Tech Ltdhttp://m.marketwired.com/press-release/northern-aspect-files-filing-statement-regarding-qualifying-transaction-with-blockchain-nex-board-nth.h-2067198.htm
alexios1201
30/10/2015
10:02
I hope that buy is a mate of mine I was preaching VELA to yesterday.

DC

daicaprice
28/10/2015
07:58
Press article relating to our Portr investment .... airportr partnership at Gatwick


hxxp://www.blandgroup.com/general-news/skybreak-adds-bag-free-travel-with-airportr/



Antony Laiker

antonyvelatech
Chat Pages: Latest  19  18  17  16  15  14  13  12  11  10  9  8  Older

Your Recent History

Delayed Upgrade Clock